Health Insurance Literacy and Challenges in Accessing Health Services in Niemann-Pick
Understanding Health Insurance Literacy and Challenges in Accessing Health Services in Niemann-Pick Disease Through the Eyes of Patients and Families
1 other identifier
observational
76
1 country
1
Brief Summary
This study is a US based qualitative PRO research study to document the health insurance literacy as well as the patient experience in Niemann-Pick as it relates to accessing desired care, services and medications for patients. The outcome of this research will be used to inform various other workstreams as NNPDF works to assist families. The core research objectives are to understand the following from Niemann-Pick patients and their families in the US
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2020
CompletedFirst Submitted
Initial submission to the registry
July 10, 2020
CompletedFirst Posted
Study publicly available on registry
July 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 21, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 21, 2020
CompletedOctober 6, 2020
October 1, 2020
3 months
July 10, 2020
October 5, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Health Insurance Literacy
Health insurance literacy will be measured by a score on a brief quiz regarding health insurance key terms as well as self-ratings regarding various aspects of the participants' ability to navigate and understand insurance
July 2020- September
Health Insurance Coverage
Health insurance coverage will be measured by the different multiple choice and open-ended questions based on the services available under the participants' insurance plan as well as their reported difficulty with navigating their plan and obtaining what they need for Niemann-Pick
July 2020- September
Study Arms (7)
Niemann-Pick Type A
Also referred to as Infantile Neurovisceral ASMD
Niemann-Pick Type A/B
Also referred to as Intermediate form or Chronic Neurovisceral ASMD
Niemann-Pick Type B
Also referred to as Chronic Visceral ASMD
Niemann-Pick Type C (Early Infantile)
Onset at less than 2 years of age
Niemann-Pick Type C (Late Infantile)
Neurodegenerative form (late-infantile) onset at 2-6 years of age
Niemann-Pick Type C (Juvenile)
Neurodegenerative form (juvenile) onset at 6-15 years of age
Niemann-Pick Type C (Adult)
Psychiatric neurodegenerative form (adult) onset at greater than 15 years of age
Eligibility Criteria
Within the United States, patients or the parent/caregiver of patients who have been diagnosed with any of the 7 known subtypes of Niemann-Pick disease
You may qualify if:
- Participant must be a person with Niemann-Pick disease who is 18 years or older or The parent/legal guardian of a person with Niemann-Pick disease. Please note: Parents whose child has passed on are able to participate in the RSVP. Parents whose child has passed on in the last two years are also able to participate in the interview. Please note that only one family member will be eligible to complete the RSVP and interview for one family.
- Confirmed diagnosis of Niemann-Pick disease, confirmed by membership in the NNPDF or by provision of a proof of disease form
- Able to read, write and communicate in English
- Able to grant informed consent
- Willing to complete a survey and RSVP, and to participate in a 30-minute telephone interview
- Ability to view or receive a document from the interviewer before or during the interview (web browser, ability to receive a text, fax or document by mail)
You may not qualify if:
- \- Inability to meet any of the above 6 criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Niemann-Pick Disease Foundationlead
- Engage Health Inc.collaborator
- Icahn School of Medicine at Mount Sinaicollaborator
Study Sites (1)
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
George A Diaz, MD, PhD
Icahn School of Medicine at Mount Sinai
- STUDY CHAIR
Justin Hopkin, MD
National Niemann-Pick Disease Board Chair
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 10, 2020
First Posted
July 14, 2020
Study Start
June 15, 2020
Primary Completion
September 21, 2020
Study Completion
September 21, 2020
Last Updated
October 6, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- September 2020
The data for each question in the study will be analyzed and reported by Engage Health using descriptive statistics as appropriate for the nature of the data collected-frequency distributions, cross tabulations and measures of central tendency and dispersion.